Medicine composition for treating primary glomerular hematuria caused by failure of spleen to control blood vessels
A primary and glomerular technology, applied in the field of medicine, can solve the primary glomerular hematuria that has not been seen, the treatment has no effective treatment method, and the pathogenesis of primary glomerular hematuria is unclear and other problems, to achieve the effect of improving glomerular filtration rate, significant clinical curative effect and reducing the number of
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0034] A pharmaceutical composition for the treatment of primary glomerular hematuria with non-unified spleen blood type, the weight ratio of each raw material is as follows:
[0035] Root 6g, Panax 6g, Myrtle 6g, Pilele 6g, Ginseng Reed 6g, Aralia 6g, Licorice 6g.
Embodiment 2
[0037] A pharmaceutical composition for the treatment of primary glomerular hematuria with non-unified spleen blood type, the weight ratio of each raw material is as follows:
[0038] Root 5g, Acanthopanax short handle 7g, myrtle 5g, Pilele 7g, ginseng reed 7g, aralia 5g, licorice 7g.
Embodiment 3
[0040] A pharmaceutical composition for the treatment of primary glomerular hematuria with non-unified spleen blood type, the weight ratio of each raw material is as follows:
[0041] Root 7g, Acanthopanax short handle 5g, myrtle 7g, Pilele 5g, ginseng reed 5g, aralia japonica 7g, licorice 5g.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com